帕金森病


Parkinson’s Disease Therapeutic Area User Guide v1.0

Please Sign in or Sign up to access links to the Therapeutic Area files.


Links
Critical Path for Parkinson's Consortium achieves EMA support
Striving for an integrated drug-development process for neurodegeneration: the coalition against major diseases
Published User Guides
Terminology
SDTM


Articles
TAUG Examples of SDTM Domains
What Do We Mean When We Say Provisional?
Why Would a Standards Development Organization Make Non-standard Variables Available on their Website?

All Public Reviews
Falls Efficacy Scale (FES)
Comments Due by:
Chinese Translation of SDTMIG v3.3, ADaMIG v1.3 & OCCDS v1.1 Metadata
Comments Due by:


Application of CDISC Standards has supported the discovery of clinical research biomarkers for Parkinson’s Disease — the evidence for which had been hidden in non-standardized datasets for years prior to their standardization, aggregation, and analysis. These biomarkers now enable researchers to identify diseases early, when intervention may be possible.